Literature DB >> 22290207

Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.

Astrid M Bedoya1,2, Roberto Jaramillo3, Armando Baena1,2, Jorge Castaño4, Natalia Olaya4, Arnold H Zea5, Rolando Herrero6, Gloria I Sanchez7.   

Abstract

Only a small proportion of women infected with Human Papillomavirus (HPV) develop cervical cancer. Host immune response seems to play a role eliminating the viral infection and preventing progression to cancer. Characterization of tumor infiltrating lymphocytes (TILs) in cervical pre-neoplastic lesions and cervical cancer may be helpful to understand the mechanisms that mediate this protection. The aim of this study was to determine if there are differences in the localization and density (cells/mm(2)) of CD8+ T-cells, CD4+ T-cells and Tregs (CD25 + Foxp3+) in cervical pre-neoplastic lesions and cervical cancer. Immunohistochemical analysis of sections of 96 (26 CIN1, 21 CIN2, 25 CIN3, and 24 SCC) samples revealed that regardless of CIN grades, CD8+ T-cells are more abundant than CD4+, CD25+ and Foxp3+ cells in both the stroma and epithelium. There was a higher density of CD8+ cells in the stroma of cervical cancer compared to CIN3 (OR = 4.20, 95% CI 1.2-15), CIN2 (OR = 7.86, 95% CI 1.7-36.4) and CIN1 (OR = 4.25, 95% CI 1.1-17). Studies evaluating whether these cells are recruited before or after cancer progression will be helpful to understand the role of these cells in the natural history of HPV-induced lesions.

Entities:  

Keywords:  Cervical cancer; HPV infection; Immunohistochemistry; Tumor infiltrating cells

Year:  2012        PMID: 22290207      PMCID: PMC3601215          DOI: 10.1007/s12307-012-0097-8

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  36 in total

Review 1.  Tumor microenvironment is multifaceted.

Authors:  Catherine Sautès-Fridman; Julien Cherfils-Vicini; Diane Damotte; Sylvain Fisson; Wolf Hervé Fridman; Isabelle Cremer; Marie-Caroline Dieu-Nosjean
Journal:  Cancer Metastasis Rev       Date:  2011-03       Impact factor: 9.264

2.  High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.

Authors:  Sytse J Piersma; Ekaterina S Jordanova; Mariëtte I E van Poelgeest; Kitty M C Kwappenberg; Jeanette M van der Hulst; Jan W Drijfhout; Cornelis J M Melief; Gemma G Kenter; Gert Jan Fleuren; Rienk Offringa; Sjoerd H van der Burg
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  CD8+ T lymphocytes are recruited to neoplastic cervix.

Authors:  M C Bell; R P Edwards; E E Partridge; K Kuykendall; W Conner; H Gore; E Turbat-Herrara; P A Crowley-Nowick
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

4.  Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy.

Authors:  J Biggerstaff; B Weidow; A Amirkhosravi; J L Francis
Journal:  BMC Immunol       Date:  2006-07-21       Impact factor: 3.615

5.  Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.

Authors:  K Syrjänen; M Hakama; S Saarikoski; M Väyrynen; M Yliskoski; S Syrjänen; V Kataja; O Castrén
Journal:  Sex Transm Dis       Date:  1990 Jan-Mar       Impact factor: 2.830

6.  Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

Authors:  E L Franco; L L Villa; J P Sobrinho; J M Prado; M C Rousseau; M Désy; T E Rohan
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

7.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

8.  Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.

Authors:  Ingeborg Zehbe; Andreas M Kaufmann; Markus Schmidt; Hanni Hohn; Markus J Maeurer
Journal:  J Immunother       Date:  2007 Jul-Aug       Impact factor: 4.456

9.  Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer.

Authors:  B S Nedergaard; M Ladekarl; H F Thomsen; J R Nyengaard; K Nielsen
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

10.  Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.

Authors:  Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Journal:  BMJ       Date:  2009-07-28
View more
  9 in total

1.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

Authors:  Dan Song; Hong Li; Haibo Li; Jianrong Dai
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

2.  Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study.

Authors:  Sabrina Zidi; Mouna Stayoussef; Bano L Alsaleh; Ezzedine Gazouani; Amel Mezlini; Bashayer H Ebrahim; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2016-10-08       Impact factor: 3.201

Review 3.  Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get".

Authors:  Ehsan Soleymaninejadian; Paola Zelini; Irene Cassaniti; Fausto Baldanti; Mattia Dominoni; Andrea Gritti; Barbara Gardella
Journal:  Vaccines (Basel)       Date:  2022-05-06

4.  Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.

Authors:  Ting-Yan Shi; Mei-Ling Zhu; Jing He; Meng-Yun Wang; Qiao-Xin Li; Xiao-Yan Zhou; Meng-Hong Sun; Zhi-Ming Shao; Ke-Da Yu; Xi Cheng; Xiaohua Wu; Qingyi Wei
Journal:  Hum Genet       Date:  2012-11-20       Impact factor: 4.132

5.  The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case-control study.

Authors:  Fanglin Niu; Tianchang Wang; Jing Li; Mengdan Yan; Dianzhen Li; Bin Li; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2018-11-20       Impact factor: 2.183

6.  Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu.

Authors:  Ninu Maskey; Niresh Thapa; Muna Maharjan; Girishma Shrestha; Narayani Maharjan; Hongbing Cai; Shangqin Liu
Journal:  Cancer Manag Res       Date:  2019-08-14       Impact factor: 3.989

7.  Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.

Authors:  Tamara R Litwin; Sarah R Irvin; Rebecca L Chornock; Vikrant V Sahasrabuddhe; Margaret Stanley; Nicolas Wentzensen
Journal:  Br J Cancer       Date:  2020-12-01       Impact factor: 7.640

8.  An Altered Ratio of CD4+ And CD8+ T Lymphocytes in Cervical Cancer Tissues and Peripheral Blood – A Prognostic Clue?

Authors:  Diptimoy Das; Basab Sarkar; Sandip Mukhopadhyay; Chandranath Banerjee; Supreeti Biswas Mondal
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26

9.  HPV Induces Changes in Innate Immune and Adhesion Molecule Markers in Cervical Mucosa With Potential Impact on HIV Infection.

Authors:  Alan Messala A Britto; Livia R Goes; Aida Sivro; Cintia Policarpo; Ângela R Meirelles; Yara Furtado; Gutemberg Almeida; James Arthos; Claudia Cicala; Marcelo A Soares; Elizabeth S Machado; Ana Lúcia M Giannini
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.